Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: A randomized crossover trial

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Canfora, Emanuel E ^a,b   Van Der Beek, Christina M ^a,b   Jocken, Johan W E ^a,b   Goossens, Gijs H ^a,b   Holst, Jens J ^c   Olde Damink, Steven W M ^a,d   Lenaerts, Kaatje ^a,b   Dejong, Cornelis H C ^a,b,e   Blaak, Ellen E ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; FAT; PROPIONIC ACID; PROPIONIC ACID DERIVATIVE; VOLATILE FATTY ACID;

ADULT; COLON; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY METABOLISM; HUMAN; MALE; METABOLISM; OBESITY; OXIDATION REDUCTION REACTION; PARENTERAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

ACETIC ACID; ADULT; BUTYRIC ACID; COLON; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENERGY METABOLISM; FASTING; FATS; FATTY ACIDS, VOLATILE; HUMANS; INFUSIONS, PARENTERAL; MALE; OBESITY; OVERWEIGHT; OXIDATION-REDUCTION; POSTPRANDIAL PERIOD; PROPIONATES;

EID: 85019847333     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02546-x     Document Type: Article

References (51)

1. Delzenne, N. M., Cani, P. D., Everard, A., Neyrinck, A. M. & Bindels, L. B. Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia 58, 2206-2217, doi: 10.1007/s00125-015-3712-7 (2015).
2. Canfora, E. E., Jocken, J. W. & Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11, 577-591, doi: 10.1038/nrendo.2015.128 (2015).
3. Kellow, N. J., Coughlan, M. T. & Reid, C. M. Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials. British Journal of Nutrition 111, 1147-1161, doi: 10.1017/S0007114513003607 (2014).
4. Tolhurst, G. et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364-371, doi: 10.2337/db11-1019 (2012).
5. Brooks, L. et al. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Molecular Metabolism 6, 48-60, doi: 10.1016/j.molmet.2016.10.011 (2017).
6. Psichas, A. et al. The short chain fatty acid propionate stimulates Glp-1 and Pyy secretion via free fatty acid receptor 2 in rodents. International journal of obesity 39, 424-429, doi: 10.1038/ijo.2014.153 (2015).
7. Bloemen, J. G. et al. Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clinical nutrition 28, 657-661, doi: 10.1016/j.clnu.2009.05.011 (2009).
8. Sahuri-Arisoylu, M. et al. Reprogramming of hepatic fat accumulation and'browning'of adipose tissue by the short-chain fatty acid acetate. International Journal of Obesity 40, 955-963 doi: 10.1038/ijo.2016.23 (2016).
9. Ge, H. et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149, 4519-4526, doi: 10.1210/en.2008-0059 (2008).
10. Ohira, H. et al. Butyrate Attenuates Inflammation and Lipolysis Generated by the Interaction of Adipocytes and Macrophages. Journal of atherosclerosis and thrombosis 20, 425-42 doi: 10.5551/jat.15065 (2013).
11. Al-Lahham, Sa. H. et al. Regulation of adipokine production in human adipose tissue by propionic acid. European journal of clinical investigation 40, 401-407, doi: 10.1111/eci.2010.40.issue-5 (2010).
12. Hong, Y. H. et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146, 5092-9, doi: 10.1210/en.2005-0545 (2005).
13. Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-17, doi: 10.2337/db08-1637 (2009).
14. den Besten, G. et al. Short-Chain Fatty Acids protect against High-Fat Diet-Induced Obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes 64, 2398-408. doi: 10.2337/db14-1213 (2015).
15. Lin, H. V. et al. Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms. PLoS ONE 7, e35240, doi: 10.1371/journal.pone.0035240 (2012).
16. Perry, R. J. et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature 534, 213-217, doi: 10.1038/nature18309 (2016).
17. van der Beek, C. M. et al. Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clinical Science 130, 2073-82; doi: 10.1042/cs20160263 (2016).
18. Bliss, D. Z. et al. In Vitro Degradation and Fermentation of Three Dietary Fiber Sources by Human Colonic Bacteria. Journal of agricultural and food chemistry 61, 4614-21, doi: 10.1021/jf3054017 (2013).
19. Stewart, M. et al. Fermentability of resistant starch preparations varies in vitro. Dietary fibre: new frontiers for food and health, Wageningen Academic Publishers, 339-49, doi: 10.3920/978-90-8686-692-2 (2010).
20. Kaur, A., Rose, D. J., Rumpagaporn, P., Patterson, J. A. & Hamaker, B. R. In Vitro Batch Fecal Fermentation Comparison of Gas and Short-Chain Fatty Acid Production Using "Slowly Fermentable" Dietary Fibers. Journal of food science 76, H137-H142, doi: 10.1111/j.1750-3841.2011.02172.x (2011).
21. Venema, K. Microbial metabolites produced by the colonic microbiota as drivers for immunomodulation in the host. The FASEB Journal 27, 643.12 (2013).
22. Wong, J. M., de Souza, R., Kendall, C. W., Emam, A. & Jenkins, D. J. Colonic health: fermentation and short chain fatty acids. Journal of clinical gastroenterology 40, 235-243, doi: 10.1097/00004836-200603000-00015 (2006).
23. Cummings, J., Pomare, E., Branch, W., Naylor, C. & Macfarlane, G. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221-7, doi: 10.1136/gut.28.10.1221 (1987).
24. Wolever, T., Brighenti, F., Royall, D., Jenkins, A. & Jenkins, D. Effect of rectal infusion of short chain fatty acids in human subjects. The American journal of gastroenterology 84, 1027-33 (1989).
25. Freeland, K. R. & Wolever, T. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-Alpha. British Journal of Nutrition 103, 460-466, doi: 10.1017/S0007114509991863 (2010).
26. Simpson, E. et al. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut 46, 73-77, doi: 10.1136/gut.46.1.73 (2000).
27. Boets, E. et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: A stable isotope study. The Journal of Physiology 595, 541-5. doi: 10.1113/JP272613 (2016).
28. Ritz, P. et al. Effects of colonic fermentation on respiratory gas exchanges following a glucose load in man. Metabolism 42, 347-352, doi: 10.1016/0026-0495(93)90085-3 (1993).
29. Yamashita, H. et al. Effects of acetate on lipid metabolism in muscles and adipose tissues of type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Bioscience, biotechnology, and biochemistry 73, 570-576, doi: 10.1271/bbb.80634 (2009).
30. Yamashita, H. et al. Improvement of obesity and glucose tolerance by acetate in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Bioscience, biotechnology, and biochemistry 71, 1236-1243, doi: 10.1271/bbb.60668 (2007).
31. De Silva, A. et al. The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell metabolism 14, 700-706, doi: 10.1016/j.cmet.2011.09.010 (2011).
32. Batterham, R. L. et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450, 106-109, doi: 10.1038/nature06212 (2007).
33. Batterham, R. L. et al. Inhibition of food intake in obese subjects by peptide YY3-36. New England Journal of Medicine 349, 941-948, doi: 10.1056/NEJMoa030204 (2003).
34. van den Hoek, A. M. et al. Chronic PYY 3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice. American Journal of Physiology-Endocrinology and Metabolism 292, E238-E245, doi: 10.1152/ajpendo.00239.2006 (2007).
35. Sloth, B., Holst, J. J., Flint, A., Gregersen, N. T. & Astrup, A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. American Journal of Physiology-Endocrinology and Metabolism 292, E1062-E1068, doi: 10.1152/ajpendo.00450.2006 (2007).
36. Fernandes, J., Vogt, J. & Wolever, T. Kinetic model of acetate metabolism in healthy and hyperinsulinaemic humans. European journal of clinical nutrition 68, 1067-71, doi: 10.1038/ejcn.2014.136 (2014).
37. Crouse, J. R., Gerson, C. D., DeCarli, L. M. & Lieber, C. S. Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. Journal of lipid research 9, 509-512 (1968).
38. Aberdein, N., Schweizer, M. & Ball, D. Sodium acetate decreases phosphorylation of hormone sensitive lipase in isoproterenol-stimulated 3T3-L1 mature adipocytes. Adipocyte 3, 121-5, doi: 10.4161/adip.27936 (2014).
39. Girousse, A. et al. Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol 11, e1001485, doi: 10.1371/journal.pbio.1001485 (2013).
40. Patel, T. B., DeBuysere, M. S. & Olson, M. S. The effect of propionate on the regulation of the pyruvate dehydrogenase complex in the rat liver. Archives of biochemistry and biophysics 220, 405-414, doi: 10.1016/0003-9861(83)90430-7 (1983).
41. Chambers, E. S. et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744-54, doi: 10.1136/gutjnl-2014-307913 (2014).
42. Corpeleijn, E., Saris, W. & Blaak, E. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. obesity reviews 10, 178-193, doi: 10.1111/obr.2009.10.issue-2 (2009).
43. den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54, 2325-40, doi: 10.1194/jlr.R036012 (2013).
44. Byrne, C. S. et al. Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods. The American journal of clinical nutrition 104, 5-14, doi: 10.3945/ajcn.115.126706 (2016).
45. Adriaens, M. P., Schoffelen, P. F. & Westerterp, K. R. Intra-individual variation of basal metabolic rate and the influence of daily habitual physical activity before testing. Br J Nutr 90, 419-423, doi:S0007114503001429 [pii] (2003).
46. Nyman-Pantelidis, M., Nilsson, A., Wagner, Z. & Borgå, O. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis. Alimentary pharmacology & therapeutics 8, 617-622 (1994).
47. Kersten, S. et al. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arteriosclerosis, thrombosis, and vascular biology 29, 969-974, doi: 10.1161/ATVBAHA.108.182147 (2009).
48. Orskov, C., Rabenhoj, L., Wettergren, A., Kofod, H. & Holst, J. J. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43, 535-539, doi: 10.2337/diab.43.4.535 (1994).
49. van Eijk, H. M., Bloemen, J. G. & Dejong, C. H. Application of liquid chromatographyÄìmass spectrometry to measure short chain fatty acids in blood. Journal of Chromatography B 877, 719-724, doi: 10.1016/j.jchromb.2009.01.039 (2009).
50. Weir, J. B. V. New methods for calculating metabolic rate with special reference to protein metabolism. The Journal of physiology 109, 1-9, doi: 10.1113/jphysiol.1949.sp004363 (1949).
51. Frayn, K. Calculation of substrate oxidation rates in vivo from gaseous exchange. Journal of Applied Physiology 55, 628-34 (1983).